ES2059828T3 - Un procedimiento para la preparacion de un compuesto. - Google Patents

Un procedimiento para la preparacion de un compuesto.

Info

Publication number
ES2059828T3
ES2059828T3 ES89902123T ES89902123T ES2059828T3 ES 2059828 T3 ES2059828 T3 ES 2059828T3 ES 89902123 T ES89902123 T ES 89902123T ES 89902123 T ES89902123 T ES 89902123T ES 2059828 T3 ES2059828 T3 ES 2059828T3
Authority
ES
Spain
Prior art keywords
formula
hydrogen
compound
introducing
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89902123T
Other languages
English (en)
Inventor
John Francis Debernardis
David Lloyd Arendsen
Robert E Zelle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2059828T3 publication Critical patent/ES2059828T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/64—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un procedimiento para la preparación de un compuesto de fórmula: **fórmula** o una de sus sales farmacéuticamente aceptables, que comprende los procedimientos de introducir R3 y -CH2CH2R4 en el grupo amino de un compuesto **fórmula** donde el procedimiento de introducir R3 comprende la reacción con R10COOH o uno de sus derivados haluro de ácido, éster o éster activado, donde R10 es hidrógeno, metilo o etilo, seguida de reducción de la amida resultante; y donde el procedimiento de introducir - CH2CH2R4 comprende la reacción con R11COOH o uno de sus derivados haluro de ácido, éster o éster activado, donde R11 es **fórmula** donde R1 y R2 se eligen independientemente entre hidrógeno, hidroxi, halógeno, alcoxi C1-2, tioalcoxi C1-2 y alquilo C1-3; oR1 y R2 tomados juntos forman un puente metilendioxi o etilendioxi; R3 es alquilo C1-3; R4 se elige entre **fórmula** donde Y es O o S, R6 es hidrógeno, metoxi ohalógeno y m es 0 o 1; R5 es hidrógeno, alquilo C1-3, fenilo o fenilo sustituido donde elanillo de fenilo está sustituido con uno, dos o tres sustituyentes elegidos independientemente entre alquilo C1-3, halógeno, hidroxi, alcoxi C1-2, amino y tioalcoxi C1-3; seguida de reducción de la amida resultante.
ES89902123T 1988-01-15 1989-01-13 Un procedimiento para la preparacion de un compuesto. Expired - Lifetime ES2059828T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14436388A 1988-01-15 1988-01-15

Publications (1)

Publication Number Publication Date
ES2059828T3 true ES2059828T3 (es) 1994-11-16

Family

ID=22508255

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89902123T Expired - Lifetime ES2059828T3 (es) 1988-01-15 1989-01-13 Un procedimiento para la preparacion de un compuesto.

Country Status (7)

Country Link
US (1) US5089519A (es)
EP (2) EP0396620B1 (es)
JP (1) JP2673024B2 (es)
CA (1) CA1338894C (es)
DE (1) DE68908392T2 (es)
ES (1) ES2059828T3 (es)
WO (1) WO1989006534A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69018864D1 (de) * 1989-03-22 1995-06-01 Ciba Geigy Ag Neue Benzothiopyranylamine.
DE4135474A1 (de) * 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
US5792767A (en) * 1995-01-27 1998-08-11 Abbott Laboratories Bicyclic substituted hexahydrobenz e! isoindole alpha-1 adrenergic antagonists
US5541199A (en) * 1995-06-02 1996-07-30 American Home Products Corporation Chroman-2-ylmethylamino derivatives
US5670667A (en) * 1995-07-25 1997-09-23 American Home Products Corporation Chroman-2-ylmethylamino derivatives
US5684039A (en) * 1995-07-25 1997-11-04 American Home Products Corporation Chroman-2-ylmethylamino derivatives
US5663194A (en) * 1995-07-25 1997-09-02 Mewshaw; Richard E. Chroman-2-ylmethylamino derivatives
DE19540995A1 (de) * 1995-11-03 1997-05-07 Hoechst Ag Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19542306A1 (de) * 1995-11-14 1997-05-15 Hoechst Ag Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
PL316439A1 (en) * 1995-11-20 1997-05-26 Hoechst Ag Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such
DE19546736A1 (de) * 1995-12-14 1997-06-19 Hoechst Ag Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate
DE19624155A1 (de) * 1996-06-18 1998-01-08 Hoechst Ag Substituierte Benzoesäurederivate, Verfahren zu ihrer Herstellung und die Anwendung der Verbindungen zur Behandlung von Krankheiten
DE19647000A1 (de) * 1996-11-14 1998-05-20 Hoechst Ag 3-Amido-chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
NZ560666A (en) * 2005-03-29 2010-01-29 Newron Pharm Spa Substituted aminoalkyl- and amidoalkyl-benzopyran derivatives
JP5280357B2 (ja) * 2006-07-07 2013-09-04 スティーブン・ピー・ガベック Ｐｄｅ４の二環式ヘテロアリール阻害剤
IT1392387B1 (it) 2008-09-26 2012-03-02 Solmag S P A Ora Fidia Farmaceutici S P A Processo per la preparazione di rotigotina

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5919549B2 (ja) * 1976-01-01 1984-05-07 武田薬品工業株式会社 異節環状化合物
JPS59110690A (ja) * 1982-12-16 1984-06-26 Dai Ichi Seiyaku Co Ltd ベンゾピラン誘導体
DE3300004A1 (de) * 1983-01-03 1984-07-12 Bayer Ag, 5090 Leverkusen Substituierte 4-aminomethylenchromane bzw. -chromene, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3411993A1 (de) * 1984-03-31 1985-10-10 Bayer Ag, 5090 Leverkusen Substituierte benzopyrane, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimittel
DE3411992A1 (de) * 1984-03-31 1985-10-10 Bayer Ag, 5090 Leverkusen Substituierte 4-hydroxy-benzopyrane, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4801605A (en) * 1986-08-29 1989-01-31 Ciba-Geigy Corporation 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans

Also Published As

Publication number Publication date
JP2673024B2 (ja) 1997-11-05
EP0396620A1 (en) 1990-11-14
JPH03502325A (ja) 1991-05-30
US5089519A (en) 1992-02-18
WO1989006534A1 (en) 1989-07-27
DE68908392T2 (de) 1994-02-10
EP0396620A4 (en) 1991-01-23
DE68908392D1 (de) 1993-09-16
EP0396620B1 (en) 1993-08-11
CA1338894C (en) 1997-02-04
EP0325964A1 (en) 1989-08-02

Similar Documents

Publication Publication Date Title
ES2059828T3 (es) Un procedimiento para la preparacion de un compuesto.
MX9504349A (es) Derivados de aroilpiperidina.
FI80877B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara spiro/4,(3+n)/-2-azaalkan-3-karboxylsyraderivat och vid framstaellning av dessa anvaendbara foerening.
MY104376A (en) N-imidazolyl deravatives of bicyclic compounds and process for their preparation.
FI93353B (fi) Menetelmä ACAT-inhiboivien kinoliinijohdannaisten valmistamiseksi
FI880742A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten, 7-asemassa substituoitujen 19-norsteroidien valmistamiseksi
DE3777852D1 (de) Dekahydrochinolinderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
GEP19970818B (en) Method of n-/2-/4-fluorphenyl/-1-methyl/-ethyl-n-methyl-n-propinylamine production
ES2058173T3 (es) Dioxialquilenaril-dihidropiridinas, productos intermedios para su fabricacion, procedimientos para su fabricacion y su utilizacion.
HUP0001396A2 (hu) 3-Amino-3 aril-propán-1-ol-származékok, előállításuk és felhasználásuk
GB1459065A (en) Therapeutic thiophene derivatives
ES466366A1 (es) Un procedimiento para preparar derivados de metasulfonamido-benzamida.
SE8003823L (sv) Nya 3-formylmetylcefalosporiner och forfarande for framstellning derav
SE7501365L (es)
PT83726B (pt) Processo para preparacao de derivados da beta-carbolina substituidas por grupos fenoxi e de composicoes farmaceuticas que os contem
SE7608152L (sv) Ny metod for framstellning av orto-aminobutyrofenonderivat och salter derav
ES8305336A1 (es) "un metodo de preparar una 4-ariloxi-1,2,3,4-tetrahidroisoquinoleina".
SE8703343D0 (sv) Derivat av 2,3,4,5,6,7-hexahydro-2,7-metano-1,5-bensoxazonin (resp -1,4-bensoxazonin), forfarande for framstellning derav och lekemedel, som innehaller denna forening
ES8603377A1 (es) Un procedimiento para la preparacion de nuevos derivados de feniletanamina.
GB1425501A (en) Substituted benzodioxoles
PT92494A (pt) Processo para a preparacao de novos derivados do indol
PT83975B (pt) Processo para a preparacao de derivados de 5-aminoalquil-beta-carbolinas e de composicoes farmaceuticas que os contem
DK52383A (da) Fremgangsmaade til fremstilling af carbacyklinderivater
AR009122A1 (es) Derivados de cafalosporin pridinio, procedimiento para su preparacion, preparaciones farmaceuticas que los contienen y empleo de dichos derivados
ES535628A0 (es) Procedimiento para preparar nuevos compuestos heterociclicos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 396620

Country of ref document: ES